JulieELangMD
General Surgery • Cleveland, OHBreast, Surgical Oncology (Other than Breast)
Chief of Breast Surgery, Co-Leader Breast Cancer Program, The Cleveland Clinic, Cleveland OH
Dr. Lang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
9500 Euclid Ave A80
Cleveland, OH 44195Phone+1 216-636-2843- Is this information wrong?
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Breast Surgical Oncology, 2006 - 2007
University of California (San Francisco)Residency, Surgery, 1999 - 2006
University of North Carolina at Chapel Hill School of MedicineClass of 1999
Certifications & Licensure
AZ State Medical License 2007 - 2025
OH State Medical License 2020 - 2024
CA State Medical License 2001 - 2024
TX State Medical License 2006 - 2008- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Top Doctor, Breast Surgery Los Angeles Magazine, 2020
- Top Doctors 2013, Breast Oncology Pasadena Magazine
- Fellow (FACS) American College of Surgeons
Clinical Trials
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer Start of enrollment: 2010 Mar 01
- Study of Topical SOR007 Ointment for Cutaneous Metastases Start of enrollment: 2018 Jan 31
- Harvest of CTCs From MBC Patients Using the Parsortix™ PC1 System Start of enrollment: 2018 Mar 29
Publications & Presentations
PubMed
- Precision Oncology in Breast Cancer Surgery.Abbasi, A., Wu, V., Lang, J., Esserman, L.> ;Surgical Oncology Clinics of North America. 2024 Apr 1
- Integrated Proteogenomic Analysis Reveals Distinct Potentially Actionable Therapeutic Vulnerabilities in Triple-Negative Breast Cancer Subtypes.Pushpinder Kaur, Alexander Ring, Tania B Porras, Guang Zhou, Janice Lu, Irene Kang, Julie E Lang> ;Cancers. 2024 Jan 25
- Adjuvant Trastuzumab Emtansine Versus Paclitaxel and Trastuzumab in Stage I HER2-Positive Breast Cancer: The ATEMPT Trial.Khattak, M., Chichura, A., Lang, J.> ;Annals of Surgical Oncology. 2024 Mar 1
- Join now to see all
Journal Articles
- RNA-Seq of Circulating Tumor Cells in Stage II–III Breast CancerMichael F Press, Julie E Lang, Annals of Surgical Oncology
Press Mentions
Promise of CTCs in Metastatic Breast Cancer ManagementJanuary 3rd, 2023- ANGLE Receives FDA Clearance for ParsortixMay 25th, 2022
- NanOlogy Publishes Results from a Phase 1/2 Clinical Trial of Its Topical Investigational Drug in the Treatment of Cutaneous Metastases of Breast CancerMay 3rd, 2022
- Join now to see all
Professional Memberships
- Member
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
